{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:25:09Z","timestamp":1787646309627,"version":"build-2736575974"},"reference-count":167,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"European Alliance of Associations for Rheumatology","award":["Research Voucher Q125RSV219"],"award-info":[{"award-number":["Research Voucher Q125RSV219"]}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Advances in Musculoskeletal"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:p>Frailty has recently emerged as a significant concern in the field of rheumatology due to the increasing representation of older adults with inflammatory arthritis (IA) and their heightened susceptibility to developing this condition. The impact of frailty on patient functioning, quality of life (QoL), and disability is substantial, and its relatively early onset in this population also places a burden on healthcare systems. This narrative review examines the prevalence, risk factors, management, and impact of frailty in rheumatoid arthritis (RA), axial spondyloarthritis (axSpA), and psoriatic arthritis (PsA). A comprehensive search of the MEDLINE\/PubMed, SCOPUS, and DOAJ databases was conducted to identify relevant articles. Several factors contribute to the development of frailty, with the strongest evidence linking the condition to advanced age, disease activity and duration, pain intensity, and nutritional status. The absence of standardised assessment tools, combined with substantial heterogeneity in frailty definitions across both the general and rheumatological populations, creates difficulties when comparing findings across studies. Treatment of the underlying disease also affects frailty. While methotrexate has been shown to offer protection, and NSAIDs\/glucocorticoids have been demonstrated to be detrimental, biologic DMARDs appear to have a neutral effect on frailty. However, their capacity to reduce long-term disease activity may offer indirect benefits that have not yet been reflected in direct data. Furthermore, the treatment of frail patients is challenging due to their increased susceptibility to adverse events and reduced treatment response. Non-pharmacological interventions, particularly those that incorporate individualised physical activity and a balanced diet rich in omega-3 fatty acids, have been identified as playing a critical role in the management of frailty. Frailty is a significant challenge in inflammatory rheumatic diseases, though studies in rheumatoid arthritis currently dominate the evidence base. While this review synthesises the available, disease-specific data for PsA and axSpA, many clinical insights for these populations still rely on extrapolation. Consequently, these findings are framed as hypothesis-generating, highlighting a critical need for further targeted research to bridge these evidence gaps.<\/jats:p>","DOI":"10.1177\/1759720x261479921","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T11:44:33Z","timestamp":1787399073000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Frailty in rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis: Current evidence and knowledge gaps"],"prefix":"10.1177","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0100-6147","authenticated-orcid":false,"given":"Izabela","family":"Kr\u00f3l","sequence":"first","affiliation":[{"name":"University Hospital in Krak\u00f3w"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1650-8928","authenticated-orcid":false,"given":"Bohdana","family":"Doskaliuk","sequence":"additional","affiliation":[{"name":"Ivano-Frankivsk National Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4188-8486","authenticated-orcid":false,"given":"Olena","family":"Zimba","sequence":"additional","affiliation":[{"name":"University Hospital in Krak\u00f3w"},{"name":"National Institute of Geriatrics, Rheumatology and Rehabilitation"},{"name":"Danylo Halytsky Lviv National Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1749-9739","authenticated-orcid":false,"given":"Mariusz","family":"Korkosz","sequence":"additional","affiliation":[{"name":"University Hospital in Krak\u00f3w"},{"name":"Jagiellonian University Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,8,22]]},"reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-019-04486-5"},{"issue":"2","key":"e_1_3_5_3_2","first-page":"274","article-title":"Frailty syndrome in rheumatoid arthritis and symptomatic osteoarthritis: an emerging concept in rheumatology","volume":"91","author":"Salaffi F","year":"2020","unstructured":"Salaffi F, Farah S, Di Carlo M. Frailty syndrome in rheumatoid arthritis and symptomatic osteoarthritis: an emerging concept in rheumatology. Acta Bio-Medica Atenei Parm 2020; 91(2): 274\u2013296, PubMed PMID: 32420963; PubMed Central PMCID: PMC7569610. https:\/\/doi.org\/10.23750\/abm.v91i2.9094","journal-title":"Acta Bio-Medica Atenei Parm"},{"issue":"4","key":"e_1_3_5_4_2","first-page":"585","article-title":"Frailty in seropositive rheumatoid arthritis patients of working age: a cross-sectional study","volume":"37","author":"Haider S","year":"2019","unstructured":"Haider S, Grabovac I, Berner C, et al. Frailty in seropositive rheumatoid arthritis patients of working age: a cross-sectional study. Clin Exp Rheumatol 2019; 37(4): 585\u2013592, PubMed PMID: 30557129.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40520-020-01667-0"},{"key":"e_1_3_5_6_2","unstructured":"Frailty - MeSH - NCBI [Internet]. [cited 2025 Dec 3]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/mesh\/?term=frailty"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/56.3.M146"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/59.3.M255"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.576134"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/gln064"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-83991-7"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glp012"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31786-6"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2016.12.005"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j4208"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12603-011-0110-9"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-022-00768-6"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)62167-9"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-011-1999-3"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204015"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.30155"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30173-8"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12529-017-9648-1"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.70162"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.47360\/1995-4484-2023-569-575"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2015.12.003"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-021-02722-9"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/62.7.722"},{"issue":"3","key":"e_1_3_5_29_2","first-page":"488","article-title":"The Comprehensive Rheumatologic Assessment of Frailty (CRAF): development and validation of a multidimensional frailty screening tool in patients with rheumatoid arthritis","volume":"38","author":"Salaffi F","year":"2020","unstructured":"Salaffi F, Di Carlo M, Farah S, et al. The Comprehensive Rheumatologic Assessment of Frailty (CRAF): development and validation of a multidimensional frailty screening tool in patients with rheumatoid arthritis. Clin Exp Rheumatol 2020; 38(3): 488\u2013499, PubMed PMID: 31694748.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.11051"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24747"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-021-05938-7"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bonr.2020.100284"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-017-3541-9"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.13359"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.11640"},{"issue":"1","key":"e_1_3_5_37_2","first-page":"315","article-title":"Disease activity at baseline is an independent predictor of frailty at one year in pre-frail patients with rheumatoid arthritis; a multicenter retrospective observational study","volume":"29","author":"Ohashi Y","year":"2024","unstructured":"Ohashi Y, Takahashi N, Sobue Y, et al. Disease activity at baseline is an independent predictor of frailty at one year in pre-frail patients with rheumatoid arthritis; a multicenter retrospective observational study. J Orthop Sci Off J Jpn Orthop Assoc 2024; 29(1): 315\u2013320, PubMed PMID: 36460559. https:\/\/doi.org\/10.1016\/j.jos.2022.10.025","journal-title":"J Orthop Sci Off J Jpn Orthop Assoc"},{"key":"e_1_3_5_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.14946"},{"key":"e_1_3_5_39_2","doi-asserted-by":"publisher","DOI":"10.14283\/jfa.2020.1"},{"key":"e_1_3_5_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-84479-0"},{"key":"e_1_3_5_41_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-020-00202-3"},{"key":"e_1_3_5_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2019.06.006"},{"key":"e_1_3_5_43_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-020-01752-1"},{"key":"e_1_3_5_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.11388"},{"key":"e_1_3_5_45_2","doi-asserted-by":"publisher","DOI":"10.1002\/acr.25282"},{"key":"e_1_3_5_46_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-021-05744-1"},{"key":"e_1_3_5_47_2","doi-asserted-by":"publisher","DOI":"10.1186\/s41927-024-00394-7"},{"key":"e_1_3_5_48_2","doi-asserted-by":"publisher","DOI":"10.3390\/nu13041259"},{"key":"e_1_3_5_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.archger.2021.104455"},{"key":"e_1_3_5_50_2","doi-asserted-by":"publisher","DOI":"10.1111\/ggi.13795"},{"key":"e_1_3_5_51_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-023-06639-z"},{"key":"e_1_3_5_52_2","doi-asserted-by":"publisher","DOI":"10.46497\/ArchRheumatol.2025.11039"},{"key":"e_1_3_5_53_2","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.14591"},{"key":"e_1_3_5_54_2","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.15034"},{"key":"e_1_3_5_55_2","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.70181"},{"issue":"7","key":"e_1_3_5_56_2","first-page":"1528","article-title":"Kihon Checklist validation in patients with rheumatoid arthritis: Italian translation, cross-cultural adaptation, and evaluation of the validity in comparison to two frailty screening tools based on the Fried phenotype and deficit accumulation model","volume":"41","author":"Salaffi F","year":"2023","unstructured":"Salaffi F, Farah S, Di Carlo M. Kihon Checklist validation in patients with rheumatoid arthritis: Italian translation, cross-cultural adaptation, and evaluation of the validity in comparison to two frailty screening tools based on the Fried phenotype and deficit accumulation model. Clin Exp Rheumatol 2023; 41(7): 1528\u20131536, PubMed PMID: 37199223. https:\/\/doi.org\/10.55563\/clinexprheumatol\/r9ufbo","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_5_57_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-020-01472-3"},{"key":"e_1_3_5_58_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-024-07200-2"},{"key":"e_1_3_5_59_2","doi-asserted-by":"publisher","DOI":"10.4103\/injr.injr_208_22"},{"key":"e_1_3_5_60_2","unstructured":"Maastricht University [Internet]. [cited 2025 Sep 10]. Prevalence of frailty and pre-frailty in patients with rheumatoid arthritis: a systematic literature review and meta-analysis. Available from. https:\/\/cris.maastrichtuniversity.nl\/en\/publications\/prevalence-of-frailty-and-pre-frailty-in-patients-with-rheumatoid\/fingerprints\/"},{"key":"e_1_3_5_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31785-4"},{"key":"e_1_3_5_62_2","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.220954"},{"key":"e_1_3_5_63_2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-207524"},{"key":"e_1_3_5_64_2","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22328"},{"key":"e_1_3_5_65_2","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2021-002111"},{"key":"e_1_3_5_66_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-53431-3"},{"key":"e_1_3_5_67_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-022-06147-6"},{"key":"e_1_3_5_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101515"},{"key":"e_1_3_5_69_2","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afw214"},{"key":"e_1_3_5_70_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2005.53300.x"},{"key":"e_1_3_5_71_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.9600-22"},{"key":"e_1_3_5_72_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-016-0374-1"},{"key":"e_1_3_5_73_2","doi-asserted-by":"publisher","DOI":"10.1186\/s42358-019-0089-1"},{"key":"e_1_3_5_74_2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201299"},{"key":"e_1_3_5_75_2","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150648"},{"key":"e_1_3_5_76_2","doi-asserted-by":"publisher","DOI":"10.1186\/s43166-025-00310-y"},{"key":"e_1_3_5_77_2","first-page":"45","article-title":"Beyond Rheumatoid Arthritis Evaluation: What are We Missing?","volume":"13","author":"Espinoza G","year":"2021","unstructured":"Espinoza G, Maldonado G, Narvaez J, et al. Beyond Rheumatoid Arthritis Evaluation: What are We Missing? Open Access Rheumatol Res Rev 2021; 13: 45\u201355, PubMed PMID: 33790666; PubMed Central PMCID: PMC8007602. https:\/\/doi.org\/10.2147\/OARRR.S298393","journal-title":"Open Access Rheumatol Res Rev"},{"issue":"6","key":"e_1_3_5_78_2","first-page":"1496","article-title":"Associations of frailty with RA-ILD and poor control of disease activity in patients with rheumatoid arthritis: A multi-center retrospective observational study","volume":"29","author":"Ohashi Y","year":"2024","unstructured":"Ohashi Y, Takahashi N, Sobue Y, et al. Associations of frailty with RA-ILD and poor control of disease activity in patients with rheumatoid arthritis: A multi-center retrospective observational study. J Orthop Sci Off J Jpn Orthop Assoc 2024; 29(6): 1496\u20131502, PubMed PMID: 38044213. https:\/\/doi.org\/10.1016\/j.jos.2023.11.012","journal-title":"J Orthop Sci Off J Jpn Orthop Assoc"},{"issue":"11","key":"e_1_3_5_79_2","first-page":"2475","article-title":"Comorbidity in arthritis","volume":"26","author":"Gabriel SE","year":"1999","unstructured":"Gabriel SE, Crowson CS, O\u2019Fallon WM. Comorbidity in arthritis. J Rheumatol 1999; 26(11): 2475\u20132479, PubMed PMID: 10555912.","journal-title":"J Rheumatol"},{"key":"e_1_3_5_80_2","doi-asserted-by":"publisher","DOI":"10.12688\/wellcomeopenres.17208.1"},{"key":"e_1_3_5_81_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.40565"},{"key":"e_1_3_5_82_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-017-0649-5"},{"key":"e_1_3_5_83_2","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glx225"},{"key":"e_1_3_5_84_2","doi-asserted-by":"publisher","DOI":"10.3390\/nu15163500"},{"key":"e_1_3_5_85_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-025-05908-1"},{"key":"e_1_3_5_86_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2013.92"},{"key":"e_1_3_5_87_2","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.170773"},{"key":"e_1_3_5_88_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2018.07.004"},{"key":"e_1_3_5_89_2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210715"},{"key":"e_1_3_5_90_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.37723"},{"key":"e_1_3_5_91_2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-207511"},{"key":"e_1_3_5_92_2","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.13380"},{"key":"e_1_3_5_93_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1565909"},{"key":"e_1_3_5_94_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.20612"},{"key":"e_1_3_5_95_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61704-9"},{"key":"e_1_3_5_96_2","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.101009"},{"key":"e_1_3_5_97_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-015-0341-2"},{"issue":"2","key":"e_1_3_5_98_2","first-page":"101","article-title":"Safety and efficacy of interleukin inhibitors in elderly patients with rheumatoid arthritis, psoriasis, and psoriatic arthritis","volume":"71","author":"Djureti\u0107 J","year":"2021","unstructured":"Djureti\u0107 J, Bufan B. Safety and efficacy of interleukin inhibitors in elderly patients with rheumatoid arthritis, psoriasis, and psoriatic arthritis. Arch Pharm 2021; 71(Notebook 2): 101\u2013119. https:\/\/doi.org\/10.5937\/arhfarm71-30505","journal-title":"Arch Pharm"},{"key":"e_1_3_5_99_2","doi-asserted-by":"publisher","DOI":"10.1111\/ggi.14375"},{"key":"e_1_3_5_100_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31591-4"},{"key":"e_1_3_5_101_2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-221035"},{"key":"e_1_3_5_102_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780270401"},{"key":"e_1_3_5_103_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-225185"},{"key":"e_1_3_5_104_2","volume-title":"World population ageing, 2017: highlights [Internet]","year":"2017","unstructured":"World population ageing, 2017: highlights [Internet]. UN; 2017 [cited 2025 Sep 28]. (Population studies \/ Department of Economic and Social Affairs; no. 397). Available from: https:\/\/digitallibrary.un.org\/record\/3799351"},{"issue":"2","key":"e_1_3_5_105_2","first-page":"85","article-title":"[Evaluation of the Amor criteria for spondylarthropathies and European Spondylarthropathy Study Group (ESSG). A cross-sectional analysis of 2,228 patients]","volume":"142","author":"Amor B","year":"1991","unstructured":"Amor B, Dougados M, Listrat V, et al. [Evaluation of the Amor criteria for spondylarthropathies and European Spondylarthropathy Study Group (ESSG). A cross-sectional analysis of 2,228 patients]. Ann Med Interne (Paris) 1991; 142(2): 85\u201389, PubMed PMID: 2064170.","journal-title":"Ann Med Interne (Paris)"},{"key":"e_1_3_5_106_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-015-0280-y"},{"key":"e_1_3_5_107_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0085309"},{"key":"e_1_3_5_108_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2019.00219"},{"key":"e_1_3_5_109_2","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/6507692"},{"key":"e_1_3_5_110_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-016-1155-z"},{"key":"e_1_3_5_111_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000014431"},{"issue":"3","key":"e_1_3_5_112_2","first-page":"351","article-title":"Effect of age at disease onset in the clinical profile of spondyloarthritis: a study of 1424 Brazilian patients","volume":"30","author":"Skare TL","year":"2012","unstructured":"Skare TL, Leite N, Bortoluzzo AB, et al. Effect of age at disease onset in the clinical profile of spondyloarthritis: a study of 1424 Brazilian patients. Clin Exp Rheumatol 2012; 30(3): 351\u2013357, PubMed PMID: 22510473.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_5_113_2","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000001904"},{"key":"e_1_3_5_114_2","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000001612"},{"key":"e_1_3_5_115_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu177"},{"key":"e_1_3_5_116_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel127"},{"key":"e_1_3_5_117_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.075309"},{"key":"e_1_3_5_118_2","doi-asserted-by":"publisher","DOI":"10.1097\/SPC.0b013e32835242d2"},{"key":"e_1_3_5_119_2","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glac006"},{"key":"e_1_3_5_120_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.035287"},{"key":"e_1_3_5_121_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-01132-6"},{"key":"e_1_3_5_122_2","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0000000000000729"},{"key":"e_1_3_5_123_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-012-8302-6"},{"key":"e_1_3_5_124_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-022-00810-7"},{"key":"e_1_3_5_125_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40359-025-02889-5"},{"key":"e_1_3_5_126_2","doi-asserted-by":"publisher","DOI":"10.1186\/s41927-019-0111-6"},{"key":"e_1_3_5_127_2","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.14110"},{"key":"e_1_3_5_128_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000024833"},{"key":"e_1_3_5_129_2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202075"},{"key":"e_1_3_5_130_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.013003"},{"key":"e_1_3_5_131_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.011189"},{"key":"e_1_3_5_132_2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203291"},{"key":"e_1_3_5_133_2","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S132940"},{"key":"e_1_3_5_134_2","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2021-002168"},{"key":"e_1_3_5_135_2","doi-asserted-by":"publisher","DOI":"10.1097\/PHM.0000000000000564"},{"key":"e_1_3_5_136_2","doi-asserted-by":"publisher","DOI":"10.22141\/pjs.12.4.2022.349"},{"key":"e_1_3_5_137_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker330"},{"key":"e_1_3_5_138_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2015.04.010"},{"key":"e_1_3_5_139_2","doi-asserted-by":"publisher","DOI":"10.3928\/01477447-20210817-01"},{"key":"e_1_3_5_140_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0749-0690(18)30377-X"},{"key":"e_1_3_5_141_2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddt375"},{"key":"e_1_3_5_142_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.05.039"},{"key":"e_1_3_5_143_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-015-0068-2"},{"key":"e_1_3_5_144_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-022-00614-3"},{"key":"e_1_3_5_145_2","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afac274"},{"issue":"15","key":"e_1_3_5_146_2","first-page":"7380","article-title":"Modulation of inflammation and immunity by omega-3 fatty acids: a possible role for prevention and to halt disease progression in autoimmune, viral, and age-related disorders","volume":"27","author":"Poggioli R","year":"2023","unstructured":"Poggioli R, Hirani K, Jogani VG, et al. Modulation of inflammation and immunity by omega-3 fatty acids: a possible role for prevention and to halt disease progression in autoimmune, viral, and age-related disorders. Eur Rev Med Pharmacol Sci 2023; 27(15): 7380\u20137400. https:\/\/doi.org\/10.26355\/eurrev_202308_33310, PubMed PMID: 37606147.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"e_1_3_5_147_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12603-018-1153-y"},{"key":"e_1_3_5_148_2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-309957"},{"key":"e_1_3_5_149_2","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2765"},{"key":"e_1_3_5_150_2","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000008"},{"key":"e_1_3_5_151_2","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.114.105833"},{"key":"e_1_3_5_152_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780380813"},{"key":"e_1_3_5_153_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1447-0594.2011.00703.x"},{"key":"e_1_3_5_154_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjopharm.2007.12.002"},{"key":"e_1_3_5_155_2","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.18372"},{"key":"e_1_3_5_156_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20153738"},{"key":"e_1_3_5_157_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2018.00108"},{"key":"e_1_3_5_158_2","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.11064"},{"key":"e_1_3_5_159_2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203407"},{"key":"e_1_3_5_160_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0136968"},{"key":"e_1_3_5_161_2","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/62.7.744"},{"key":"e_1_3_5_162_2","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.050051"},{"key":"e_1_3_5_163_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2003.18.12.2083"},{"key":"e_1_3_5_164_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(18)30091-4"},{"key":"e_1_3_5_165_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep195"},{"key":"e_1_3_5_166_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket169"},{"key":"e_1_3_5_167_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12603-021-1609-3"},{"key":"e_1_3_5_168_2","doi-asserted-by":"publisher","DOI":"10.1111\/jhn.12072"}],"container-title":["Therapeutic Advances in Musculoskeletal Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1759720X261479921","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1759720X261479921","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1759720X261479921","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T07:47:28Z","timestamp":1787644048000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1759720X261479921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":167,"alternative-id":["10.1177\/1759720X261479921"],"URL":"https:\/\/doi.org\/10.1177\/1759720x261479921","relation":{},"ISSN":["1759-720X","1759-7218"],"issn-type":[{"value":"1759-720X","type":"print"},{"value":"1759-7218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]},"article-number":"1759720X261479921"}}